Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin.
AUTOR(ES)
Forney, J R
RESUMO
The combined effect of the serine protease inhibitor alpha-1-antitrypsin (AAT) and the aminoglycoside paromomycin on Cryptosporidium parvum infection in vitro was investigated. AAT and paromomycin were mixed with C. parvum oocysts as either single or combined treatments and used to inoculate epithelial cell cultures. Single- and combined-treatment groups had significantly lower (P < 0.01) parasite numbers than untreated controls. The mean fractional inhibitory concentration indices suggested significant synergistic activity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164053Documentos Relacionados
- Alpha-1-antitrypsin bodies in the liver.
- Alpha-1-antitrypsin in human macrophages.
- Genetic Heterogeneity of Rabbit Alpha-1-Antitrypsin
- Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals.
- Interrelationships between the Human Alveolar Macrophage and Alpha-1-Antitrypsin
